Financials

  • Market Capitalization 8.09 B
  • Employee 3 100
  • Founded 1976
  • CEO Charles R. Kummeth
  • Website www.bio-techne.com
  • Headquarter Minnesota, United States
  • FIGI BBG000C15114
  • Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
75.74
Relación precio/flujo de caja
6.8
Dividendos por acción
0.08
Rendimiento por dividendo, %
1.07

Bio-Techne Corp - Common Stock

Bio-Techne Corporation is an American life sciences company that develops, manufactures and sells life science reagents, instruments and services for the research, diagnostic, and bioprocessing markets.

Noticias